Comparison of concomitant drug confirmation methods in community pharmacies for patients using multiple drugs
Not Applicable
- Conditions
- Patients prescribed diuretics and renin-angiotensin system inhibitors (angiotensin converting enzyme inhibitorsACEI or angiotensin II receptor blockersABR)
- Registration Number
- JPRN-UMIN000047550
- Lead Sponsor
- Shiga Pharmaceutical Association Kaiei Pharmacy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who failed to obtain consent to the study 2. Patients or agents unable to respond to telephone calls, such as cognitive decline or hearing loss
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber and type of concomitant drugs
- Secondary Outcome Measures
Name Time Method umber of pharmacists consultation to prescribing physician, and renal function